Casper Marc N sells $12.8M of TMOCasper Marc N 内部减持 赛默飞 (TMO) $12.8M
Thermo Fisher Scientific (TMO) Insider Sale Filing
On August 21, 2026, Casper Marc N, Chairman & CEO, Director, and Officer of Thermo Fisher Scientific (Ticker: TMO), sold 20,321 common shares on the open market at $628.11 per share, for a total transaction value of $12,763,764.31. The corresponding Form 4 insider transaction filing was submitted to the U.S. SEC on August 24, 2026. The sale represents 0.005% of TMO’s current $233.7 billion total market capitalization, making it a modest position adjustment.
As a core company executive, this sale is far smaller in scale than recent open-market trades by other TMO insiders: for example, two combined sales by Chief HR Officer Britt Lisa P. on August 20 totaled over $11.7 million, while multiple sales by Executive Vice President Shafer Michael D. on August 13 totaled over $22 million. This transaction falls into the category of routine small-scale insider selling, rather than a signal of major strategic divestment.
This filing was submitted concurrently with a second TMO Form 4 on August 24, 2026, and falls within a recent wave of insider filings: since August 10, 2026, at least seven Form 4 transactions from TMO executives have been submitted to the SEC, covering trades by the Chief Accounting Officer, Executive Vice President, and other core roles. Additionally, 13F institutional holding data as of December 31, 2025, shows TMO has 2,738 institutional holders, with total holdings of $218.3 billion representing 100.2% of the company’s float, with 355 new positions opened and 1,284 institutions increasing their stakes during the reporting period.
Follow-up markers and signal limits
This signal does not confirm the company’s intrinsic valuation, future earnings guidance, or the personal financial motivations of the selling executive. The submitted Form 4 filing does not disclose whether the transaction was executed under a pre-arranged 10b5-1 plan, so it cannot be determined if this was a routine, planned sale. Follow-up items to monitor include additional TMO insider transaction filings, the company’s Q3 2026 earnings report scheduled for October 28, 2026, and updates to institutional holdings in the next 13F filing cycle.
赛默飞世尔（TMO）高管内幕减持申报
2026年8月21日，赛默飞世尔科技（股票代码：TMO）董事长兼首席执行官、董事兼高管CASPER MARC N以每股628.11美元的公开市场价格出售20,321股普通股，交易总价值12,763,764.31美元，相关Form 4内幕交易申报文件于2026年8月24日提交至美国SEC。该笔交易占TMO当前2337亿美元总市值的0.005%，属于小额持仓调整。
作为公司核心高管，本次减持规模远低于近期其他TMO高管的公开市场交易：例如8月20日首席人力资源官Britt Lisa P.的两笔减持总价值超1170万美元，8月13日执行副总裁Shafer Michael D.的多笔减持总价值超2200万美元，本次交易属于常规小额套现，而非重大战略减持信号。
本次申报与8月24日SEC提交的另一份TMO Form 4文件同期披露，且属于8月10日以来的密集内幕交易申报周期：截至目前已有至少7笔高管Form 4交易提交，涵盖首席会计官、执行副总裁等多位核心岗位人员。此外，截至2025年12月31日的13F机构持仓数据显示，TMO共有2738家机构持有者，总持仓规模达2183亿美元，占流通股的100.2%，报告期内有355家新建仓、1284家机构加仓。
后续关注与信号边界
该信号无法证明公司内在估值、未来业绩指引或高管个人财务动机，且申报文件未提及本次交易是否依据10b5-1预先安排计划执行，无法判断是否为常规计划内套现。后续需跟踪TMO后续的高管内幕交易申报、2026年10月28日即将发布的季度财报，以及下一期机构持仓13F申报更新。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。